The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The Relationship between Apoptosis and High-Mobility Group Protein 1 Release from Murine Macrophages Stimulated with Lipopolysaccharide or Polyinosinic-Polycytidylic Acid
Abstract
High-mobility group protein 1 (HMGB1) is a nonhistone nuclear protein whose function depends on cellular location. Inside the cell, HMGB1 modulates a variety of important cellular processes, including transcription, whereas outside the cell, HMGB1 acts as a cytokine that can promote inflammation and mediate sepsis and arthritis in animal models. In in vitro studies, proinflammatory molecules such as LPS, lipoteichoic acid, polyinosinic-polycytidylic acid (poly(I:C)), TNF-α, and type I and II IFNs can induce HMGB1 release from macrophages. Although these agents can activate cells, they can also induce apoptosis under certain circumstances. Therefore, because of evidence that apoptotic as well as necrotic cells can contribute to HMGB1-mediated events in sepsis, we have investigated the relationship between apoptosis and HMGB1 release in macrophages and other cells. In these experiments, using RAW 264.7 cells as a model, LPS and poly(I:C) caused HMGB1 release into the medium whereas CpG ODN failed to induce this response. With both LPS and poly(I:C), the extent of HMGB1 release correlated with the occurrence of apoptosis as measured by caspase 3 activation, lactate dehydrogenase release, and TUNEL staining. Similar results were obtained with primary murine macrophages as well as human Jurkat T cells. For Jurkat cells, poly(I:C) and NO donors induced apoptosis as well as HMGB1 release. Together, these results indicate that HMGB1 release from macrophages is correlated with the occurrence of apoptosis and suggest that these processes reflect common mechanisms and can occur concomitantly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although it was initially thought that HMGB1 is released only from the nucleus during primary necrosis, recent data indicate that HMGB1 can be released during secondary necrosis following apoptosis 27,48–50.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [50]
Citations
Cites
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 4,022
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,286
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068
Takeda, K., & Akira, S. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.003 · Cited by 2,528
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., & Bianchi, M. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,252
Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T., & Seya, T. (2003) · Nature Immunology · doi:10.1038/ni886 · Cited by 1,217
Nitric oxide-mediated apoptosis in murine peritoneal macrophages
Albina, J. E., Cui, S., Mateo, R. B., & Reichner, J. S. (1993) · Parasitology Today · doi:10.1016/0169-4758(93)90226-6 · Cited by 782
Research works printed but not linked: 43
- 2003, Biochem. Biophys. Res. Commun., 421
- 2003, Nucleic Acids Res., 3236
- 2005, Nat. Rev. Immunol., 331
- 1999, Science, 248
- 2005, J. Leukocyte Biol., 930
- 2003, Arthritis Rheum., 2052
- 2003, EMBO J., 5551
- 2006, J. Immunol., 7889
- 2002, Nature, 191
- 2006, Am. J. Physiol., C1318
- 1987, J. Interferon Res., 511
- 1997, J. Exp. Med., 1831
- 2000, Blood, 3823
- 2004, J. Immunol., 1699
- 2003, J. Immunol., 3890
- 2006, J. Immunol., 3337
- 1993, J. Immunol., 5080
- 1997, Cell Growth Differ., 343
- 1999, J. Infect. Dis., 939
- 1998, Biochem. Biophys. Res. Commun., 790
- 1994, Mol. Cell. Biol., 8376
- 2004, Semin. Immunol., 3
- 1999, Surgery, 389
- 1997, Cancer Res., 3697
- 2001, Oncogene, 4768
- 2002, J. Hepatol., 233
- 2007, J. Leukocyte Biol., 75
- 2003, Am. J. Physiol., C1235
- 2006, J. Immunol., 4894
- 1997, Parasitology, S79
- 1991, J. Virol., 2968
- 1995, Cancer Res., 6012
- 1996, Am. J. Respir. Cell Mol. Biol., 64
- 1998, J. Exp. Med., 2175
- 1999, J. Biol. Chem., 28808
- 2004, Biochem. Biophys. Res. Commun., 60
- 2000, EMBO J., 3630
- 2004, Nat. Immunol., 730
- 2003, Nat. Immunol., 161
- 2003, Science, 640
- 2005, Nat. Chem. Biol., 112
- 2003, J. Exp. Med., 1441
- 2006, J. Exp. Med., 1637
Cited by
Sorted by citations
HMGB1 and RAGE in Inflammation and Cancer
Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., & Coyle, A. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132603 · Cited by 1,436
Immunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176
Novel role of PKR in inflammasome activation and HMGB1 release
Lü, B., Nakamura, T., Inouye, K., Li, J., Tang, Y., Lundbäck, P., Valdés‐Ferrer, S. I., Olofsson, P. S., Kalb, T. H., Roth, J., et al. (2012) · Nature · doi:10.1038/nature11290 · Cited by 772
HMGB1: Endogenous Danger Signaling
Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A. (2008) · Molecular Medicine · doi:10.2119/2008-00034.klune · Cited by 762
Release mechanisms of major DAMPs
Murao, A., Aziz, M., Wang, H., Brenner, M., & Wang, P. (2021) · APOPTOSIS · doi:10.1007/s10495-021-01663-3 · Cited by 590
Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation
Garg, A. D., Nowis, D., Gołąb, J., Vandenabeele, P., Krysko, D. V., & Agostinis, P. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.08.003 · Cited by 517
HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
Bertheloot, D., & Latz, E. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.34 · Cited by 455
The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Circulation Research · doi:10.1161/circresaha.109.212217 · Cited by 381
Oxidative stress-mediated HMGB1 biology
Yan, Y. Q., Tang, D., & Kang, R. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00093 · Cited by 268
TLR7 and TLR9 in SLE: when sensing self goes wrong
Celhar, T., Magalhães, R., & Fairhurst, A. (2012) · Immunologic Research · doi:10.1007/s12026-012-8270-1 · Cited by 234
Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications
Silva, M. T., do Vale, A., & dos Santos, N. M. S. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0187-8 · Cited by 235
Regulation of Tumor Progression by Programmed Necrosis
Lee, S. Y., Ju, M. K., Jeon, H. M., Jeong, E. K., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3537471 · Cited by 238
HMGB1, a potent proinflammatory cytokine in sepsis
Huang, W., Tang, Y.-Q., & Li, L. (2010) · Cytokine · doi:10.1016/j.cyto.2010.02.021 · Cited by 211
Toll‐like receptors’ two‐edged sword: when immunity meets apoptosis
Salaun, B., Romero, P. J., & Lebecque, S. (2007) · European Journal of Immunology · doi:10.1002/eji.200737744 · Cited by 184
Lee, J. Y., & Park, W. (2011) · Molecules · doi:10.3390/molecules16087132 · Cited by 137
Role of Soluble Receptor for Advanced Glycation End Products on Endotoxin-induced Lung Injury
Zhang, H., Tasaka, S., Shiraishi, Y., Fukunaga, K., Yamada, W., Seki, H., Ogawa, Y., Miyamoto, K., Nakano, Y., Hasegawa, N., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1069oc · Cited by 136
Regulation of Posttranslational Modifications of HMGB1 During Immune Responses
Tang, Y., Zhao, X. S., Antoine, D. J., Xiao, X., Wang, H., Andersson, U., Billiar, T. R., Tracey, K. J., & Lü, B. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6409 · Cited by 132
The role of HMGB1 in the pathogenesis of rheumatic disease
Andersson, U., & Harris, H. E. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.003 · Cited by 126
The dual role and therapeutic potential of high-mobility group box 1 in cancer
He, S.-J., Cheng, J. Q., Xiao, F., Yu, Y., Tian, L., & Huang, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.17885 · Cited by 126
Nakazawa, H., Chang, K., Shinozaki, S., Yasukawa, T., Ishimaru, K., Yasuhara, S., Yu, Y., Martyn, J. A. J., Tompkins, R. G., Shimokado, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170391 · Cited by 118
He, L., Liu, T., Shi, Y., Tian, F., Hu, H., Deb, D. K., Chen, Y., Bissonnette, M., & Li, Y. C. (2017) · Endocrinology · doi:10.1210/en.2017-00748 · Cited by 114
Insights into battles between Mycobacterium tuberculosis and macrophages
Xu, G., Wang, J., Gao, G. F., & Liu, C. H. (2014) · Protein & Cell · doi:10.1007/s13238-014-0077-5 · Cited by 118
Fu, L., Liu, K., Wake, H., Teshigawara, K., Yoshino, T., Takahashi, H. K., Mori, S., & Nishibori, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01325-y · Cited by 115
Wang, Q., Wang, F., Li, X., Yang, Q., Li, X., Xu, N., Huang, Y., Zhang, Q., 苟兴春, 陈绍洋, et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-24 · Cited by 108
Han, J., Zhong, J., Wei, W., Wang, Y., Huang, Y., Yang, P. C., Purohit, S. B., Dong, Z., Wang, M.-H., She, J., et al. (2008) · Diabetes · doi:10.2337/db07-1499 · Cited by 107
DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress
Kappes, F., Fahrer, J., Khodadoust, M. S., Tabbert, A., Strasser, C., Mor‐Vaknin, N., Moreno‐Villanueva, M., Bürkle, A., Markovitz, D. M., & Ferrando‐May, E. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01921-07 · Cited by 108
Insights into the Apoptotic Death of Immune Cells in Sepsis
Luan, Y., Yao, Y.-M., Xiao, X., & Sheng, Z.-Y. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0069 · Cited by 104
Zou, J., Kawai, T., Tsuchida, T., Kozaki, T., Tanaka, H., Shin, K.-S., Kumar, H., & Akira, S. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.007 · Cited by 103
High-mobility group box 1 (HMGB1) as a master regulator of innate immunity
Castiglioni, A., Canti, V., Rovere, P. Q., & Manfredi, A. A. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1033-1 · Cited by 104
Qing, D., Conegliano, D., Shashaty, M. G. S., Seo, J., Reilly, J. P., Worthen, G. S., Huh, D., Meyer, N. J., & Mangalmurti, N. S. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1095oc · Cited by 103
Gong, G., Yuan, L., Hu, L., Wu, W. H., Yin, L., Hou, J., Liu, Y., & Zhou, L.-S. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.151 · Cited by 100
Bacterial Endotoxin Induces the Release of High Mobility Group Box 1 via the IFN-β Signaling Pathway
Kim, J., Kim, S.-J., Lee, I., Lee, M., Uematsu, S., Akira, S., & Oh, K. I. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801364 · Cited by 99
Splenectomy Protects against Sepsis Lethality and Reduces Serum HMGB1 Levels
Huston, J. M., Wang, H., Ochani, M., Ochani, K., Rosas‐Ballina, M., Gallowitsch‐Puerta, M., Ashok, M., Yang, L., Tracey, K. J., & Yang, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3535 · Cited by 98
High-Mobility Group Box-1 Mediates Toll-Like Receptor 4–Dependent Angiogenesis
Lin, Q., Yang, X. P., Fang, D., Ren, X., Zhou, H., Fang, J., Liu, X., Zhou, S., Feng, W., Yao, X., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.224048 · Cited by 94
The Alarmin Properties of DNA and DNA-associated Nuclear Proteins
Magna, M., & Pisetsky, D. S. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.02.029 · Cited by 90
Self-citationDuong, A. D., Sharma, S., Peine, K. J., Gupta, G., Satoskar, A. R., Bachelder, E. M., Wyslouzil, B. E., & Ainslie, K. M. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005098 · Cited by 87
The Significance and Regulatory Mechanisms of Innate Immune Cells in the Development of Sepsis
Luan, Y., Dong, N., Xie, M., Xiao, X., & Yao, Y.-M. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0042 · Cited by 86
Microparticles as a source of extracellular DNA
Pisetsky, D. S., Gauley, J., & Ullal, A. J. (2011) · Immunologic Research · doi:10.1007/s12026-010-8184-8 · Cited by 80
Self-citationHMGB1 in the interplay between autophagy and apoptosis in cancer
Chen, R., Zou, J., Zhong, X. Y., Li, J., Kang, R., & Tang, D. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216494 · Cited by 80
LI, J., Xie, H., WEN, T., Liu, H., Zhu, W., & Chen, X. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090663 · Cited by 78
The translocation of HMGB1 during cell activation and cell death
Gauley, J., & Pisetsky, D. S. (2009) · Autoimmunity · doi:10.1080/08916930902831522 · Cited by 81
Self-citationPisetsky, D. S. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00014 · Cited by 76
Self-citationPreconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance
Aneja, R. K., Tsung, A., Sjödin, H., Gefter, J. V., Delude, R. L., Billiar, T. R., & Fink, M. P. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108030 · Cited by 75
Abdominal drains: a brief historical review.
Memon, M. A., Memon, M. A., & Donohue, J. H. (2001) · PubMed · Cited by 72
Lü, L., Yue, S., Jiang, L., Li, C., Zhu, Q., Ke, M., Lü, H., Wang, X., Busuttil, R. W., Ying, Q., et al. (2017) · Hepatology · doi:10.1002/hep.29593 · Cited by 72
The role of inflammation in epileptogenesis
Meng, F., & Yao, L. (2020) · Acta Epileptologica · doi:10.1186/s42494-020-00024-y · Cited by 75
Immune-Modulating Perspectives for Low Frequency Electromagnetic Fields in Innate Immunity
Rosado, M. M., Simkó, M., Mattsson, M., & Pioli, C. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00085 · Cited by 71
Kikuchi, K., Kawahara, K., Tancharoen, S., Matsuda, F., Morimoto, Y., Ito, T., Biswas, K. K., Takenouchi, K., Miura, N., Oyama, Y., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149484 · Cited by 67
The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis
Chen, Y., Sun, W., Gao, R., Su, Y., Umehara, H., Dong, L., & Gong, F. (2013) · Rheumatology · doi:10.1093/rheumatology/ket134 · Cited by 66
Amaral, E. P., Lasunskaia, E., & Lima, M. R. D. (2015) · Microbes and Infection · doi:10.1016/j.micinf.2015.09.005 · Cited by 70
Yamaga, S., Aziz, M., Murao, A., Brenner, M., & Wang, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1353990 · Cited by 69
Wang, Q., Ding, Q., Zhou, Y., Gou, X., Hou, L., Chen, S., Zhu, Z., & Xiong, L. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181a160d6 · Cited by 63
Albayrak, A., Uyanik, M. H., Cerrah, S., Altaş, S., Dursun, H., Demir, M. T., & Uslu, H. (2010) · Viral Immunology · doi:10.1089/vim.2010.0080 · Cited by 63
Jiang, W., & Pisetsky, D. S. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074484 · Cited by 62
Self-citationKline, K. A., Schwartz, D. J., Gilbert, N. M., Hultgren, S. J., & Lewis, A. L. (2012) · Infection and Immunity · doi:10.1128/iai.00684-12 · Cited by 63
Is HMGB1 an osteocyte alarmin?
Bidwell, J. P., Yang, J., & Robling, A. G. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21572 · Cited by 62
MARUYAMA, M. (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000172 · Cited by 58
Ebina, M., Taniguchi, H., Miyasho, T., Yamada, S., Shibata, N., Ohta, H., Hisata, S., Ohkouchi, S., Tamada, T., Nishimura, H., et al. (2011) · Pulmonary Medicine · doi:10.1155/2011/916486 · Cited by 56
Ultraviolet light exposure stimulates HMGB1 release by keratinocytes
Johnson, K. E., Wulff, B. C., Oberyszyn, T. M., & Wilgus, T. A. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1401-2 · Cited by 56
The Translocation of Nuclear Molecules During Inflammation and Cell Death
Pisetsky, D. S. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5143 · Cited by 57
Self-citationThe release of microparticles by RAW 264.7 macrophage cells stimulated with TLR ligands
Gauley, J., & Pisetsky, D. S. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0709465 · Cited by 57
Self-citationBench-to-bedside review: High-mobility group box 1 and critical illness
Fink, M. P. (2007) · Critical Care · doi:10.1186/cc6088 · Cited by 54
Interferon β protects against lethal endotoxic and septic shock through SIRT1 upregulation
Yoo, C.-H., Yeom, J.-H., Heo, J.-J., Song, E., Lee, S.-I., & Han, M. (2014) · Scientific Reports · doi:10.1038/srep04220 · Cited by 53
Hassan, H. M., Al-Wahaibi, L. H., Elmorsy, M. A., & Mahran, Y. F. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s249093 · Cited by 52
Li, Y. ‐., Kuan, Y., Huang, F. ‐., & Chang, Y. (2012) · International Endodontic Journal · doi:10.1111/j.1365-2591.2011.02001.x · Cited by 51
Damage associated molecular patterns and neutrophil extracellular traps in acute pancreatitis
Zhou, X., Jin, S., Pan, J., Lin, Q., Yang, S., Ambe, P. C., Basharat, Z., Zimmer, V., Wang, W., & Hong, W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.927193 · Cited by 51
Kawahara, K., Biswas, K. K., Unoshima, M., Ito, T., Kikuchi, K., Morimoto, Y., Iwata, M., Tancharoen, S., Oyama, Y., Takenouchi, K., et al. (2007) · Cardiovascular Pathology · doi:10.1016/j.carpath.2007.08.006 · Cited by 49
HMGB1 and Microparticles as Mediators of the Immune Response to Cell Death
Pisetsky, D. S., Gauley, J., & Ullal, A. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3865 · Cited by 50
Self-citationMast Cell Stabilization Improves Survival by Preventing Apoptosis in Sepsis
Ramos, L., Peña, G., Cai, B., Deitch, E. A., & Ulloa, L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000273 · Cited by 51
Wu, X., Gu, W., Lu, H., Liu, C., Yu, B., Xu, H., Tang, Y., Li, S., Zhou, J., & Shao, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1015390 · Cited by 48
Cytotoxicity and genotoxicity of chlorhexidine on macrophages in vitro
Li, Y., Kuan, Y., Lee, S., Huang, F., & Chang, Y. (2012) · Environmental Toxicology · doi:10.1002/tox.21771 · Cited by 46
Wang, W., Wu, L., Li, J., Ji, J., Chen, K., Yu, Q., Li, S., Feng, J., Liu, T., Zhang, J., et al. (2019) · Mediators of Inflammation · doi:10.1155/2019/3240713 · Cited by 43
Sepsis: Links between Pathogen Sensing and Organ Damage
Crouser, E. D., Exline, M. C., Knoell, D. L., & Wewers, M. D. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784980572 · Cited by 43
Zaki, A. M., El-Tanbouly, D. M., Abdelsalam, R. M., & Zaki, H. F. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.004 · Cited by 40
Lee, J., Kim, H., Lee, D., Yun, T., Koo, Y., Chae, Y., Kang, J.-H., Kang, B.-T., Yang, M.-P., & Kim, H. (2021) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16258 · Cited by 39
Pocket Epithelium in the Pathological Setting for HMGB1 Release
Ebe, N., Hara‐Yokoyama, M., Iwasaki, K., Iseki, S., Okuhara, S., Podyma‐Inoue, K. A., Terasawa, K., Watanabe, A., Akizuki, T., Watanabe, H., et al. (2010) · Journal of Dental Research · doi:10.1177/0022034510385688 · Cited by 38
The Redox Protein High-Mobility Group Box 1 in Cell Death and Cancer
Chen, R., Zou, J., Kang, R., & Tang, D. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0236 · Cited by 39
Aramburu, I. V., Hoving, D., Vernardis, S. I., Tin, M. C. F., Ιωάννου, Μ., Temkin, M. I., de Vasconcelos, N. M., Demichev, V., Helbig, E. T., Lippert, L. J., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.11.007 · Cited by 35
Daniels, W. M. U., Marais, L., Stein, D. J., & Russell, V. A. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2011.061176 · Cited by 34
Angiogenesis Mediated by Toll-Like Receptor 4 in Ischemic Neural Tissue
He, C., Sun, Y., Ren, X., Lin, Q., Hu, X., Huang, X., Su, S.-B., Liu, Y., & Liu, X. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300679 · Cited by 34
Infection and apoptosis associated with inflammation in periodontitis: An immunohistologic study
Listyarifah, D., Al‐Samadi, A., Salem, A., Syaify, A., Salo, T. A., Tervahartiala, T. I., Grenier, D., Nordström, D., Sorsa, T. A., & Ainola, M. (2017) · Oral Diseases · doi:10.1111/odi.12711 · Cited by 33
The release of high mobility group box 1 in apoptosis is triggered by nucleosomal DNA fragmentation
Yamada, Y., Fujii, T., Ishijima, R., Tachibana, H., Yokoue, N., Takasawa, R., & Tanuma, S. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.11.011 · Cited by 30
One Step Encapsulation of Small Molecule Drugs in Liposomes via Electrospray-Remote Loading
Duong, A. D., Collier, M. A., Bachelder, E. M., Wyslouzil, B. E., & Ainslie, K. M. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00528 · Cited by 30
Wang, H., Zhang, W., Lei, W.-F., Zhou, C., & Ye, T. (2011) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31820dca9f · Cited by 28
High Mobility Group Box 1: a potential therapeutic target for systemic lupus erythematosus
Pan, H., Wu, G., Li, W., Li, X.-P., & Ye, D. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9485-7 · Cited by 25
Activation-Induced CD154 Expression Abrogates Tolerance Induced by Apoptotic Cells
Gurung, P., Kucaba, T. A., Ferguson, T. A., & Griffith, T. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901676 · Cited by 26
Yang, I. V., Jiang, W., Rutledge, H. R., Lackford, B. L., Warg, L. A., Arras, L. D., Alper, S., Schwartz, D. A., & Pisetsky, D. S. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.05.015 · Cited by 24
Self-citationBorchardt, T., Looso, M., Bruckskotten, M., Weis, P., Kruse, J., & Braun, T. W. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-4 · Cited by 24
Hernández‐Pando, R., Barrios‐Payán, J., Mata‐Espinosa, D., Marquina‐Castillo, B., Hernández‐Ramírez, D. F., Botasso, O. A., & Bini, E. I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133200 · Cited by 23
Assessment of the cytotoxicity of chlorhexidine by employing an in vitro mammalian test system
Li, Y.-C., Kuan, Y., Lee, T.-H., Huang, F., & Chang, Y. (2013) · Journal of Dental Sciences · doi:10.1016/j.jds.2013.02.011 · Cited by 23
Preconditioning With High Mobility Group Box 1 (HMGB1) Induces Lipoteichoic Acid (LTA) Tolerance
Robert, S. M., Sjödin, H., Fink, M. P., & Aneja, R. K. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181dcd111 · Cited by 22
Tang, C. W., Feng, W. M., Du, H. M., Bao, Y., & Ming, Z. (2011) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.224.69 · Cited by 22
Spencer, D. M., Dye, J. R., Piantadosi, C. A., & Pisetsky, D. S. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.12.024 · Cited by 23
Self-citationThe redox protein HMGB1 in cell death and cancer
Chen, R., Zou, J., Kang, R., & Tang, D. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0007 · Cited by 22
Farias, R., & Rousseau, S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00087 · Cited by 20
Pisetsky, D. S., & Spencer, D. M. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05110-11 · Cited by 20
Self-citationThe Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33
Palumbo, A., Atzeni, F., Murdaca, G., & Gangemi, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512143 · Cited by 20
Spencer, D. M., Gauley, J., & Pisetsky, D. S. (2013) · Innate Immunity · doi:10.1177/1753425913492552 · Cited by 19
Self-citationJo, E. H., Moon, J. E., Chang, M. H., Lim, Y. J., Park, J. H., Lee, S. H., Cho, Y. R., Cho, A. E., Pack, S. P., Kim, H.-W., et al. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.06.013 · Cited by 17
Tsubota, M., Miyazaki, T., Ikeda, Y., Hayashi, Y., Aokiba, Y., Tomita, S., Sekiguchi, F., Wang, D., Nishibori, M., & Kawabata, A. (2021) · Cells · doi:10.3390/cells10102550 · Cited by 15
Metadata
- Authors
- Jiang, W., Bell, C. W., & Pisetsky, D. S.
- Affiliations
- Duke University (US)
- Corresponding author
- Jiang, Weiwen
- ORCID
- Pisetsky, David S
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05
- Volume
- 178
- Issue
- 10
- Pages
- 6495-6503
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2130822772
- Cited by
- 134
- References
- 45
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 6 · 2022: 5 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 8 · 2016: 6 · 2015: 7 · 2014: 5 · 2013: 10 · 2012: 9
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI44808)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- HMGB1, apoptosis, macrophages, lipopolysaccharide, poly(I:C), CpG oligodeoxynucleotides, caspase-3, necrosis, sepsis, inflammation, Jurkat cells, RAW 264.7 macrophages, nitric oxide donors, HMGB1 release
- MeSH terms
- Animals, Cell Line, Extracellular Space, Female, Humans, Lipopolysaccharides, Macrophage Activation, Mice, Inbred BALB C, Oligodeoxyribonucleotides, Poly I-C, Apoptosis, Macrophages, Peritoneal, Jurkat Cells, Protein Transport, HMGB1 Protein, Toll-Like Receptors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review